Exactly. The "disease modification" is about dialing down hypersensitization to pain. It doesn't touch the underlying pathology. Hard to justify the DMOAD claim.
Great to have more and better pain management options though. Good luck to them.
Exactly. The "disease modification" is about dialing down...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.0¢ | $63.43K | 270.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 213534 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 76890 | 2 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |